Oppilotech and Evariste Technologies Partnered to Develop First-in-Class Antibacterial Programme

Oppilotech Ltd., a biotechnology company specializing in the systems biology and the machine learning platforms for the purpose of building the unique predictive computational models of cells has announced a partnership of co-development drug discovery with Evariste Technologies based in United Kingdom, that is going to be using the artificial intelligence and machine learning technologies […]

Continue Reading

XORTX Therapeutics Submits Clinical Trial Application To Conduct Study on PharmacoKinetics

XORTX Therapeutics Inc., a pharmaceutical therapeutics company that is focusing on the development of the innovative therapies for the purpose of treating the progressive kidney disease announced that, it has submitted a clinical trial application (CTA) along with the Health Canada for a study of XRX-OXY-101 bridging pharmacokinetics. The XRX-OXY-101 Bridging Pharmacokinetics Study has been […]

Continue Reading